Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia
PurposeLefamulin is the first pleuromutilin antibiotic approved for the treatment of community-acquired bacterial pneumonia (CABP). However, the pharmacokinetic/pharmacodynamic (PK/PD) characteristics in Chinese CABP patients are not fully understood. This study aimed to evaluate its microbiological...
Saved in:
Main Authors: | Xingchen Bian (Author), Nanyang Li (Author), Yi Li (Author), Xu Zhu (Author), Jicheng Yu (Author), Yingying Hu (Author), Haijing Yang (Author), Qiong Wei (Author), Xiaojie Wu (Author), Jingjing Wang (Author), Guoying Cao (Author), Jufang Wu (Author), Yang Wang (Author), Jing Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
by: Yingying Hu, et al.
Published: (2023) -
Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
by: Haijing Yang, et al.
Published: (2022) -
LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA® in Chinese healthy male subjects
by: Guoying Cao, et al.
Published: (2023) -
Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes
by: Xiaojie Wu, et al.
Published: (2024) -
Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
by: Yuancheng Chen, et al.
Published: (2023)